bosentan
NDC 0591-2512, bosentan, tablet, film coated, from Actavis Pharma, Inc..
- Product NDC
- 0591-2512
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207110
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2512 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BOSENTAN125 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-2512-60 | 00591251260 | 60 TABLET, FILM COATED in 1 BOTTLE (0591-2512-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/39b2a85f-4322-42d4-b420-1b1d52569143
Use it
Look up 0591-2512 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2512 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-2512. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.